Biological E's Corbevax becomes the 2nd Covid Vaccine To Get Approval For Children In India

A second COVID-19 vaccine for children and teens has received emergency use authorisation in India.

Biological E Ltd's Corbevax has got EUA for adolescents between 12 and 18 years, the vaccine-maker said in a statement today.

To date, India has been administering Bharat Biotech's Covaxin to teens between 15 and 18 years old since January 3.

The EUA (Emergency Use Authorisation) for Corbevax's restricted use in emergency among adults was cleared by the regulator Drugs Controller General of India in December 2019.

Corbevax is administered through intramuscular route with two doses scheduled 28 days apart and is stored at 2 to 8 degree Celsius.

The Hyderabad-based firm was founded in 1953 and is the first private sector biological products company in India and the first pharmaceutical company in southern India.

Source: NDTV